• CardioExcyte 96

    Combined impedance and MEA-like recordings
  • CardioExcyte 96

    For cardiac safety screening
  • CardioExcyte 96

    Next generation label-free cell analysis
  • CardioExcyte 96

    Intuitive data analysis & arrhythmia detection
  • CardioExcyte 96

    Transparent plates available for imaging

2018 - Optogenetic control of transiently transfected hiPSC-derived cardiomyocytes for the assessment of drug related cardiotoxicity

Icon CE   CardioExcyte 96 presentation (slide deck)   logo pdf   (1.4 MB)

Presenter:
Greg Luerman, PhD, Technical Director North America, Ncardia

Source:
SOT, Ncardia & Nanion hosted session
March 12. 2018

Back to Overview

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok